Dishman Pharmaceuticals & Chemicals jumped 9.76% to Rs 76.50 at 10:05 IST on BSE, extending Tuesday's surge triggered by strong Q1 result.
Meanwhile, the BSE Sensex was down 22.08 points, or 0.13% to 17,214.10
On BSE, 7.92 lakh shares were traded in the counter as against an average daily volume of 2.12 lakh shares in the past one quarter.
The stock hit a high of Rs 79.40 and a low of Rs 72.30 so far during the day. The stock had hit a 52-week high of Rs 92 on 1 August 2011. The stock had hit 52-week low of Rs 32.50 on 23 December 2011.
The stock had outperformed the market over the past one month till 31 July 2012, gaining 7.15% compared with the Sensex's 1.11% fall. The scrip had also outperformed the market in past one quarter, surging 53.02% as against Sensex's 0.48% decline.
The small-cap pharmaceuticals company's equity capital is Rs 16.14 crore. Face value per share is Rs 2.
The Dishman Pharmaceuticals & Chemicals stock surged 17.15% in two trading sessions from Rs 65.30 on Monday, 30 August 2012 after the company reported 155.8% spurt in consolidated net profit to Rs 38.70 crore on a 30.5% rise in total income to Rs 317.92 crore in Q1 June 2012 over Q1 June 2011. The result was announced during market hours on Tuesday, 31 July 2012.
Dishman Pharmaceuticals and Chemicals' board of directors at its meeting held on Tuesday, 31 July 2012, recommended payment of dividend Rs 1.20 per equity share for the financial year ended 31 March 2012.
Dishman is a global, dynamic group of companies offering a continuum of services to the pharmaceutical industry. It is a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services.
Powered by Capital Market - Live News
